期刊文献+

高糖环境下人骨髓间充质干细胞复合兔脱细胞真皮支架体外成骨能力检测

Detection of human bone marrow mesenchymal stem cells integrate rabbit acellular dermal matrix stenting of in vitro osteogenesis ability in high glucose environment
下载PDF
导出
摘要 目的探讨脱细胞真皮支架在高糖环境下对骨髓间充质干细胞(h BMSC)的保护作用,以及促进h BMSC向成骨细胞分化的能力。方法建立脱细胞真皮基质和含300 mmol/L葡萄糖的细胞高糖模型,在高糖环境下,培养h BMSC为高糖对照组,在高糖条件下,h BMSC种植在脱细胞真皮基质上为基质实验组,正常条件下培养的h BMSC为正常对照组,每组均进行成骨细胞诱导实验。利用MTT实验检测h BMSC的增殖情况;利用骨形成蛋白-1(BMP-1)免疫荧光染色检测h BMSC成骨细胞分化情况,ELISA实验检测各组h BMSC的BMP-1、碱性磷酸酶(ALP)的含量。结果与高糖对照组比较,基质实验组h BMSC的细胞增殖光密度(OD值)升高,差异有统计学意义(P<0.01);h BMSC在脱细胞真皮基质的生长状态良好,基质实验组BMP-1染色阳性的细胞数目明显高于高糖对照组(P<0.01);基质实验组BMP-1、ALP等蛋白的含量明显增高(P<0.01)。结论高糖环境下,脱细胞真皮基质有利于促进h BMSC分化为成骨细胞。 Objective To investigate the protective effect of human bone marrow mesenchymal stem cells(h BMSC) with the acellular dermal matrix stenting in the high glucose environment, and the differentiation ability with the promotion form human bone marrow mesenchymal stem cells to osteoblasts. Methods Acellular dermal matrix and the high glucose model of containing 300 mmol/L glucose were established. With the high glucose environment, h BMSC was cultured to be the control group. With the high glucose condition, h BMSC was planted to be the acellular dermal matrix experimental group. With the normal condition, h BMSC was planted to be the normal control group. All groups had the osteoblasts induction experiment, the proliferation of h BMSC was detected by using MTT. the osteoblasts differentiation of h BMSC was detected by using fluorescence staining, and the content of BMP-1 and ALP in the experiment groups was detected by using ELISA. Results Compared with the high glucose control group, cell proliferation and matrix optical density(OD) of the h BMSC matrix experiment group was increased, with significant statistic difference(P 0.01); h BMSC was in good condition in the acellular dermal matrix. The number of BMP-1 positive cells in the culture group was significantly higher than that in the high glucose group(P 0.01); The contents of BMP-1, ALP proteins were significantly increased(P 0.01). Conclusion In the high glucose environment, the acellular dermal matrix has the significant promotion of differentiation from h BMSC to osteoblasts.
出处 《中国医药导报》 CAS 2016年第15期21-24,共4页 China Medical Herald
基金 黑龙江省教育厅面上项目(12541901)
关键词 高糖 骨髓间充质干细胞 脱细胞真皮基质 成骨细胞 High glucose Bone marrow mesenchymal stem cells Acellular dermal matrix Osteoblast
  • 相关文献

参考文献20

  • 1Poittevin M,Bonnin P,Pimpie C,et al. Diabetic microan-giopathy :impact of impaired cerebral vasoreactivity anddelayed angiogenesis after permanent middle cerebralartery occlusion on stroke damage and cerebral repair inmice [J]. Diabetes, 2014,64(3) : 999-1010.
  • 2Palmer BF,Clegg DJ. Electrolyte and Acid-Base Disturb-ances in Patients with Diabetes Mellitus [J], N Engl J Med,2015,373(6):548-559.
  • 3Stamp-Linde J, Vestergaard P. Management of endocrinedisease : Diabetes and osteoporosis : cause for concern. [J].European Journal of Endocrinology,2015,173(3) :93-99.
  • 4刘中浩,高红伟,邢德国,赵锡武,王若义,宫明智.糖尿病性骨质疏松模型雌激素、一氧化氮及转化生长因子β1的变化[J].中国组织工程研究与临床康复,2011,15(11):1953-1956. 被引量:11
  • 5Sanz AR,Carrion FS,Chaparro AP. Mesenchymal stemcells from the oral cavity and their potential value in tissueengineering [J]. Periodontol, 2015,67 (1) : 251-267.
  • 6Takami Y,Yamaguchi R,Ono S,et al. Clinical Applicationand Histological Properties of Autologous Tissue-engineeredSkin Equivalents Using an Acellular Dermal Matrix [J].Journal of Nippon Medical School,2014,81 (6) :356-363.
  • 7Moreno LA,Cox KL. Quantification of dsDNA using theHitachi F-7000 Fluorescence Spectrophotometer and Pico-Green dye [J]. J Vis Exp,2010(45) :2465.
  • 8Londono R, Badylak SF_ Regenerative Medicine Strategiesfor Esophageal Repair [J]. Tissue Eng Part B Rev,2015,21(4):393-410.
  • 9Oliveira AL,Moore Z. Treatment of the diabetic foot byoffloading:a systematic review [J]. J Wound Care,2015,24(12):560-570.
  • 10Jeon YJ,Kim J,Jin HC,et al. Comparative analysis ofhuman mesenchymal stem cells derived from bone marrow,placenta and adipose tissue as sources of cell therapy [J].Journal of Cellular Biochemistry,2015,117(5) : 1112-1125.

二级参考文献20

  • 1陶树清,潘宣超,荣杰生,王效东.转化生长因子β对大鼠成骨细胞雌激素受体表达的影响[J].中国骨质疏松杂志,2005,11(3):302-305. 被引量:13
  • 2Albright F,Reifenstein EC.Parathyroid Glands and Metabolic Bone Disease:Selected Studies.Baltimore:Williams and Wilkins.1948:150-164.
  • 3Valéria MG,Luciana A.Osteopenia:a bone disorder associated with diabetes mellitus.J Bone Miner Metab.2005;23:58-68.
  • 4Khosla S.Update on estrogens and the skeleton.J Clin Endocrinol Metab.2010;95(8):3569-3577.
  • 5Wimalawansa SJ.Restoration of ovariectomy-induced osteopenia by nitroglycerine.Calcif Tissue Int.2000;66:56-60.
  • 6Ozgocmen S,Kaya H,Fadillioglu E,et al.Effects of calcitonin,risedronate,and raloxifene on erythrocyte antioxidant enzyme activity,lipid peroxidation,and nitric oxide in postmenopausal osteoporosis.Arch Med Res.2007;38(2):196-205.
  • 7Das UN.Nitric oxide as the mediator of the antiosteoporotic actions of estrogen,statins,and essential fatty acids.Exp Biol Med (Maywood).2002;227(2):88-93.
  • 8Schwartz AV,Sellmeyer DE,Strotmeyer ES,et al.Diabetes and bone loss at the hip in older black and white adults.J Bone Miner Res.2005;20(4):596-603.
  • 9Shaarawy M,Zaki S,Sheiba M,et al.Circulating levels of osteoclast activating cytokines,interleukin-11 and transforming growth factor-beta2,as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.Clin Lab.2003;49(11-12):625-636.
  • 10Olbfich A,Rosen P,Hilgem RD,et al.Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats.J Cardiovase Pharmacol.1996;27(2):187-194.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部